PPP – Lenalidomide

Overview of the Pregnancy Prevention Programme for Thalidomide, Lenalidomide and Pomalidomide Accord

A Pregnancy Prevention Programme pack comprising all required materials for HCPs is available to download. The pack also contains materials for HCPs to give to patients

The Pregnancy Prevention Programme paper based process

Please refer to the SmPC and the Accord thalidomide/lenalidomide/pomalidomide Healthcare Professional Brochure before prescribing

Step 01

Chief pharmacist, or their appointed deputy, must first register with Accord as part of a controlled distribution system by completing and returning the Pharmacy Registration Form (PRF).

Chief Pharmacist, or their appointed deputy, must read and understand the Healthcare Professional Brochure prior to completion of the PRF

An editable pdf of the PRF can be downloaded using the link below

Details on how to return the PRF to Accord can be found on the form

Step 02

Healthcare Professional brochure

All HCPs must read and understand the brochure before prescribing or dispensing to any patient. Accord Risk Minimisation Materials can be found in the resources section

Step 03

Controlled distribution

Once registered with Accord, thalidomide/lenalidomide/pomalidomide can be obtained from our nominated controlled distributor to hospitals.

Step 04

Prescription Authorisation Forms

A PAF must accompany every prescription, and be sent to Accord at the point of dispensing to monitor the effectiveness of the PPP. Once registered, stock can be ordered by pharmacy prior to the completion and submission of a PAF.

Auditing requirements are the responsibility of Accord.

An editable pdf of the PAF can be downloaded using the link below

Details on how to return the PAF to Accord can be found on the form

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Accord-UK Ltd on 01271 385257 or email [email protected].

Please select